Unclaimed Scholar Profile
Are you Anthonet Lombard Koen? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at South African Medical Research CouncilASIDASID-5916-8739-6439 orcid.org/0000-0001-6420-8511
Anthonet Lombard Koen
South African Medical Research Council•South Africa
Faculty researcher at South African Medical Research Council (ZA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#SARS-CoV-2 and COVID-19 Research#Bacterial Infections and Vaccines#Pneumonia and Respiratory Infections#COVID-19 Clinical Research Studies
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 9,223 | 4,427 |
| h-index | 23 | 17 |
| i10-index | 31 | 22 |
Annual Citation Growth
Verified Citations / Year0
2020443
2021+40%620
2022+29%797
2023+33%1.1k
2024-8%974
2025-45%531
2026Scholarship Distribution & Proportions56 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (7,563) • 18% Global Research Impact (1,660)
56 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (56)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
DOI: 10.1016/s0140-6736(20)32661-1 Verified Peer-Reviewed
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2102214 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2103055 Verified Peer-Reviewed
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial
Published in The Lancet Infectious Diseases•2016
DOI: 10.1016/s1473-3099(16)00152-3 Verified Peer-Reviewed
Showing 1 – 5 of 56 publications
1 / 12